Ashraf Almatar1, Christopher J D Wallis1, Sender Herschorn1, Refik Saskin2, Girish S Kulkarni3, Ronald T Kodama1, Robert K Nam1. 1. Division of Urology, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, ON, Canada; 2. Institute of Evaluative Clinical Sciences, Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, ON, Canada; 3. Division of Urology, University Health Network, University of Toronto, ON, Canada.
Abstract
INTRODUCTION: Surgical volume can affect several outcomes following radical prostatectomy (RP). We examined if surgical volume was associated with novel categories of treatment-related complications following RP. METHODS: We examined a population-based cohort of men treated with RP in Ontario, Canada between 2002 and 2009. We used Cox proportional hazard modeling to examine the effect of physician, hospital and patient demographic factors on rates of treatment-related hospital admissions, urologic procedures, and open surgeries. RESULTS: Over the study interval, 15 870 men were treated with RP. A total of 196 surgeons performed a median of 15 cases per year (range: 1-131). Patients treated by surgeons in the highest quartile of annual case volume (>39/year) had a lower risk of hospital admission (hazard ratio [HR]=0.54, 95% CI 0.47-0.61) and urologic procedures (HR=0.69, 95% CI 0.64-0.75), but not open surgeries (HR=0.83, 95% CI 0.47-1.45) than patients treated by surgeons in the lowest quartile (<15/year). Treatment at an academic hospital was associated with a decreased risk of hospitalization (HR=0.75, 95% CI 0.67-0.83), but not of urologic procedures (HR=0.94, 95% CI 0.88-1.01) or open surgeries (HR=0.87, 95% CI 0.54-1.39). There was no significant trend in any of the outcomes by population density. CONCLUSIONS: The annual case volume of the treating surgeon significantly affects a patient's risk of requiring hospitalization or urologic procedures (excluding open surgeries) to manage treatment-related complications.
INTRODUCTION: Surgical volume can affect several outcomes following radical prostatectomy (RP). We examined if surgical volume was associated with novel categories of treatment-related complications following RP. METHODS: We examined a population-based cohort of men treated with RP in Ontario, Canada between 2002 and 2009. We used Cox proportional hazard modeling to examine the effect of physician, hospital and patient demographic factors on rates of treatment-related hospital admissions, urologic procedures, and open surgeries. RESULTS: Over the study interval, 15 870 men were treated with RP. A total of 196 surgeons performed a median of 15 cases per year (range: 1-131). Patients treated by surgeons in the highest quartile of annual case volume (>39/year) had a lower risk of hospital admission (hazard ratio [HR]=0.54, 95% CI 0.47-0.61) and urologic procedures (HR=0.69, 95% CI 0.64-0.75), but not open surgeries (HR=0.83, 95% CI 0.47-1.45) than patients treated by surgeons in the lowest quartile (<15/year). Treatment at an academic hospital was associated with a decreased risk of hospitalization (HR=0.75, 95% CI 0.67-0.83), but not of urologic procedures (HR=0.94, 95% CI 0.88-1.01) or open surgeries (HR=0.87, 95% CI 0.54-1.39). There was no significant trend in any of the outcomes by population density. CONCLUSIONS: The annual case volume of the treating surgeon significantly affects a patient's risk of requiring hospitalization or urologic procedures (excluding open surgeries) to manage treatment-related complications.
Authors: Quoc-Dien Trinh; Jan Schmitges; Maxine Sun; Shahrokh F Shariat; Shyam Sukumar; Marco Bianchi; Zhe Tian; Claudio Jeldres; Jesse Sammon; Paul Perrotte; Markus Graefen; James O Peabody; Mani Menon; Pierre I Karakiewicz Journal: J Urol Date: 2011-09-25 Impact factor: 7.450
Authors: Quoc-Dien Trinh; Anders Bjartell; Stephen J Freedland; Brent K Hollenbeck; Jim C Hu; Shahrokh F Shariat; Maxine Sun; Andrew J Vickers Journal: Eur Urol Date: 2013-04-19 Impact factor: 20.096
Authors: Robert K Nam; Patrick Cheung; Sender Herschorn; Refik Saskin; Jiandong Su; Laurence H Klotz; Michelle Chang; Girish S Kulkarni; Yuna Lee; Ronald T Kodama; Steven A Narod Journal: Lancet Oncol Date: 2014-01-17 Impact factor: 41.316
Authors: Robert K Nam; Sender Herschorn; D Andrew Loblaw; Ying Liu; Laurence H Klotz; Lesley K Carr; Ronald T Kodama; Aleksandra Stanimirovic; Vasundara Venkateswaran; Refik Saskin; Calvin H L Law; David R Urbach; Steven A Narod Journal: J Urol Date: 2012-06-15 Impact factor: 7.450
Authors: William T Lowrance; Elena B Elkin; Lindsay M Jacks; David S Yee; Thomas L Jang; Vincent P Laudone; Bertrand D Guillonneau; Peter T Scardino; James A Eastham Journal: J Urol Date: 2010-02-25 Impact factor: 7.450
Authors: Colin B Begg; Elyn R Riedel; Peter B Bach; Michael W Kattan; Deborah Schrag; Joan L Warren; Peter T Scardino Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Wesley W Choi; Xiangmei Gu; Stuart R Lipsitz; Anthony V D'Amico; Stephen B Williams; Jim C Hu Journal: Urol Oncol Date: 2010-09-06 Impact factor: 3.498
Authors: C J D Wallis; P Cheung; S Herschorn; R Saskin; J Su; L H Klotz; G S Kulkarni; Y Lee; R T Kodama; S A Narod; R K Nam Journal: Br J Cancer Date: 2015-03-17 Impact factor: 7.640
Authors: Arunan Sujenthiran; Julie Nossiter; Matthew Parry; Susan C Charman; Ajay Aggarwal; Heather Payne; Prokar Dasgupta; Noel W Clarke; Jan van der Meulen; Paul Cathcart Journal: BJU Int Date: 2017-11-15 Impact factor: 5.588
Authors: Naif M Alotaibi; George M Ibrahim; Justin Wang; Daipayan Guha; Muhammad Mamdani; Tom A Schweizer; R Loch Macdonald Journal: PLoS One Date: 2017-07-20 Impact factor: 3.240